The IPA wants the government to accord infrastructure status to the Active Pharmaceutical Ingredients (API) industry, and provide a boost to innovation through tax incentives on patent income, streamlined pathways for testing and approval of experimental therapies, its president, Satish Reddy told ET.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3g4ezyu
via IFTTT
0 comments:
Post a Comment